Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.1%

1 terminated out of 11 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

80% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (6)
P 2 (1)
P 3 (2)

Trial Status

Recruiting4
Completed4
Withdrawn1
Terminated1
Enrolling By Invitation1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (11)

Research Network

Activity Timeline